Metabolic Effects of Endoscopic Duodenal Mucosal Resurfacing: a Systematic Review and Meta-analysis
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | OLIVEIRA, Guilherme Henrique Peixoto de | |
dc.contributor.author | MOURA, Diogo Turiani Hourneaux de | |
dc.contributor.author | FUNARI, Mateus Pereira | |
dc.contributor.author | MCCARTY, Thomas R. | |
dc.contributor.author | RIBEIRO, Igor Braga | |
dc.contributor.author | BERNARDO, Wanderley Marques | |
dc.contributor.author | SAGAE, Vitor Massaro Takamatsu | |
dc.contributor.author | FREITAS JR., Joao Remi | |
dc.contributor.author | SOUZA, Gabriel Mayo de Vieira | |
dc.contributor.author | MOURA, Eduardo Guimaraes Hourneaux de | |
dc.date.accessioned | 2021-04-15T20:03:40Z | |
dc.date.available | 2021-04-15T20:03:40Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Duodenal mucosal resurfacing (DMR) is an innovative endoscopic bariatric and metabolic therapy (EBMT) emerging in recent years. It uses the duodenum to achieve better glycemic and weight control. This study aimed to evaluate in a critical and systematic way the metabolic effects of this procedure. Electronic searches were performed evaluating the DMR procedure based on predefined inclusion and exclusion criteria. Changes in measured outcomes were evaluated using random-effects models by computing weighted mean differences (MD) and corresponding 95% CIs between pre-and post-procedure metabolic characteristics. Four studies were selected for qualitative and quantitative analysis. DMR demonstrated beneficial glycemic and hepatic metabolic effects among patients with non-insulin dependent type 2 diabetes (T2D) at 3 and 6 months post-procedure. | eng |
dc.description.index | MEDLINE | eng |
dc.identifier.citation | OBESITY SURGERY, v.31, n.3, p.1304-1312, 2021 | |
dc.identifier.doi | 10.1007/s11695-020-05170-3 | |
dc.identifier.eissn | 1708-0428 | |
dc.identifier.issn | 0960-8923 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/40071 | |
dc.language.iso | eng | |
dc.publisher | SPRINGER | eng |
dc.relation.ispartof | Obesity Surgery | |
dc.rights | restrictedAccess | eng |
dc.rights.holder | Copyright SPRINGER | eng |
dc.subject | Duodenal mucosal resurfacing | eng |
dc.subject | DMR | eng |
dc.subject | Diabetes | eng |
dc.subject | Hydrothermal ablation | eng |
dc.subject | Hepatic steatosis | eng |
dc.subject | Systematic review | eng |
dc.subject.other | body-mass index | eng |
dc.subject.other | type-2 | eng |
dc.subject.other | health | eng |
dc.subject.other | risk | eng |
dc.subject.wos | Surgery | eng |
dc.title | Metabolic Effects of Endoscopic Duodenal Mucosal Resurfacing: a Systematic Review and Meta-analysis | eng |
dc.type | article | eng |
dc.type.category | review | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | Estados Unidos | |
hcfmusp.affiliation.countryiso | us | |
hcfmusp.author.external | MCCARTY, Thomas R.:Harvard Med Sch, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA | |
hcfmusp.citation.scopus | 22 | |
hcfmusp.contributor.author-fmusphc | GUILHERME HENRIQUE PEIXOTO DE OLIVEIRA | |
hcfmusp.contributor.author-fmusphc | DIOGO TURIANI HOURNEAUX DE MOURA | |
hcfmusp.contributor.author-fmusphc | MATEUS PEREIRA FUNARI | |
hcfmusp.contributor.author-fmusphc | IGOR BRAGA RIBEIRO | |
hcfmusp.contributor.author-fmusphc | WANDERLEY MARQUES BERNARDO | |
hcfmusp.contributor.author-fmusphc | VITOR MASSARO TAKAMATSU SAGAE | |
hcfmusp.contributor.author-fmusphc | JOAO REMI DE FREITAS JUNIOR | |
hcfmusp.contributor.author-fmusphc | GABRIEL MAYO VIEIRA DE SOUZA | |
hcfmusp.contributor.author-fmusphc | EDUARDO GUIMARAES HOURNEAUX DE MOURA | |
hcfmusp.description.beginpage | 1304 | |
hcfmusp.description.endpage | 1312 | |
hcfmusp.description.issue | 3 | |
hcfmusp.description.volume | 31 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 33417100 | |
hcfmusp.origem.scopus | 2-s2.0-85099251948 | |
hcfmusp.origem.wos | WOS:000606166300006 | |
hcfmusp.publisher.city | NEW YORK | eng |
hcfmusp.publisher.country | UNITED STATES | eng |
hcfmusp.relation.reference | Aithal G, 2019, J HEPATOL, V70, pE70, DOI 10.1016/S0618-8278(19)30124-0 | eng |
hcfmusp.relation.reference | Aldoheyan T, 2017, SURG ENDOSC, V31, P1142, DOI 10.1007/s00464-016-5082-8 | eng |
hcfmusp.relation.reference | Buhmann H, 2014, BEST PRACT RES CL GA, V28, P559, DOI 10.1016/j.bpg.2014.07.003 | eng |
hcfmusp.relation.reference | Caussy C, 2018, HEPATOLOGY, V68, P763, DOI 10.1002/hep.29797 | eng |
hcfmusp.relation.reference | Cherrington Alan D, 2017, Gastrointest Endosc Clin N Am, V27, P299, DOI 10.1016/j.giec.2016.12.002 | eng |
hcfmusp.relation.reference | Davies NK, 2019, SURG OBES RELAT DIS, V15, P656, DOI 10.1016/j.soard.2019.01.033 | eng |
hcfmusp.relation.reference | Neto AAD, 2020, OBES SURG, V30, P1971, DOI 10.1007/s11695-020-04449-9 | eng |
hcfmusp.relation.reference | de Moura EGH, 2019, ENDOSC INT OPEN, V7, pE685, DOI 10.1055/a-0862-0263 | eng |
hcfmusp.relation.reference | Eckel RH, 2011, J CLIN ENDOCR METAB, V96, P1654, DOI 10.1210/jc.2011-0585 | eng |
hcfmusp.relation.reference | Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039 | eng |
hcfmusp.relation.reference | Gerhard GS, 2013, DIABETES CARE, V36, P1859, DOI 10.2337/dc12-2255 | eng |
hcfmusp.relation.reference | Hartemink N, 2006, AM J EPIDEMIOL, V163, P1042, DOI 10.1093/aje/kwj141 | eng |
hcfmusp.relation.reference | Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557 | eng |
hcfmusp.relation.reference | Moura EGH, 2019, OBES SURG, V29, P32, DOI 10.1007/s11695-018-3470-y | eng |
hcfmusp.relation.reference | Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4 | eng |
hcfmusp.relation.reference | Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700 | eng |
hcfmusp.relation.reference | Magee C, 2018, GUT, V67, pA32, DOI 10.1136/gutjnl-2018-BSGAbstracts.61 | eng |
hcfmusp.relation.reference | McCarty Thomas R, 2020, Tech Innov Gastrointest Endosc, V22, P145, DOI 10.1016/j.tige.2020.03.008 | eng |
hcfmusp.relation.reference | Mingrone G, 2020, DIABETES, V69, DOI 10.2337/db20-121-LB | eng |
hcfmusp.relation.reference | MRAZ M, 2019, DIABETES S1, V68, DOI 10.2337/DB19-1131-P | eng |
hcfmusp.relation.reference | Mudaliar S, 2012, DIABETOLOGIA, V55, P1865, DOI 10.1007/s00125-012-2561-x | eng |
hcfmusp.relation.reference | Nauck MA, 2018, DIABETES OBES METAB, V20, P5, DOI 10.1111/dom.13129 | eng |
hcfmusp.relation.reference | Neto MG, 2016, GASTROENTEROLOGY, V150, pS174, DOI 10.1016/S0016-5085(16)30672-2 | eng |
hcfmusp.relation.reference | Pendyala S, 2012, GASTROENTEROLOGY, V142, P1100, DOI 10.1053/j.gastro.2012.01.034 | eng |
hcfmusp.relation.reference | Rajagopalan H, 2016, DIABETES CARE, V39, P2254, DOI 10.2337/dc16-0383 | eng |
hcfmusp.relation.reference | Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b | eng |
hcfmusp.relation.reference | Kotinda APST, 2020, OBES SURG, V30, P2743, DOI 10.1007/s11695-020-04558-5 | eng |
hcfmusp.relation.reference | Schauer PR, 2003, T M AM SURG ASS, V121, P160 | eng |
hcfmusp.relation.reference | Schienkiewitz A, 2006, AM J CLIN NUTR, V84, P427 | eng |
hcfmusp.relation.reference | Sherifali D, 2010, DIABETES CARE, V33, P1859, DOI 10.2337/dc09-1727 | eng |
hcfmusp.relation.reference | Starekova J, 2020, ABDOM RADIOL, V45, P3386, DOI 10.1007/s00261-020-02783-1 | eng |
hcfmusp.relation.reference | Sterne JA, 2016, BMJ | eng |
hcfmusp.relation.reference | The GRADE Working Group, 2015, GRADEPRO GUID DEV TO | eng |
hcfmusp.relation.reference | van Baar AC, 2017, UNITED EUR GASTROENT, pA161, DOI [10.1177/2050640617725676, DOI 10.1177/2050640617725676] | eng |
hcfmusp.relation.reference | van Baar ACG, 2018, UNITED EUR GASTROENT, pA135, DOI [10.1177/2050640618792819, DOI 10.1177/2050640618792819] | eng |
hcfmusp.relation.reference | van Baar A, 2019, GASTROINTEST ENDOSC, V89, pAB260, DOI 10.1016/j.gie.2019.03.293 | eng |
hcfmusp.relation.reference | van Baar Annieke C G, 2019, JHEP Rep, V1, P429, DOI 10.1016/j.jhepr.2019.10.006 | eng |
hcfmusp.relation.reference | van Baar ACG, 2020, GUT, V69, P295, DOI 10.1136/gutjnl-2019-318349 | eng |
hcfmusp.relation.reference | Van Baar ACG, 2018, GASTROENTEROLOGY, V154, P773, DOI 10.1053/j.gastro.2018.02.010 | eng |
hcfmusp.relation.reference | van Olst N, 2020, TECH INNOV GASTROINT, V22, P109, DOI [10.1016/j.tige.2020.03.003, DOI 10.1016/J.TIGE.2020.03.003] | eng |
hcfmusp.relation.reference | Verdam FJ, 2011, J CLIN ENDOCR METAB, V96, pE379, DOI 10.1210/jc.2010-1333 | eng |
hcfmusp.relation.reference | Vilar-Gomez E, 2018, J HEPATOL, V68, P305, DOI 10.1016/j.jhep.2017.11.013 | eng |
hcfmusp.relation.reference | Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047 | eng |
hcfmusp.relation.reference | World Health Organization, 2020, OB OV | eng |
hcfmusp.relation.reference | World Health Organization, 2020, DIABETES | eng |
hcfmusp.scopus.lastupdate | 2024-06-09 | |
relation.isAuthorOfPublication | a1cc8278-52e7-484d-8b45-3d62bba6c443 | |
relation.isAuthorOfPublication | 97b671af-49f1-40ee-a539-d97baba7a51f | |
relation.isAuthorOfPublication | a528753d-2a18-49dc-b6cf-756dca1aeaeb | |
relation.isAuthorOfPublication | 938f5746-02bd-4e1f-9788-086fe7962335 | |
relation.isAuthorOfPublication | c86b438c-c045-42c0-bbbb-347de72d169c | |
relation.isAuthorOfPublication | b1e7bf45-8154-4cb1-a103-6c6bf55955f4 | |
relation.isAuthorOfPublication | be9b16c9-c361-4291-a3ee-9d9660681d6c | |
relation.isAuthorOfPublication | a28fd223-a2aa-43d8-add5-2ade41c8bbb1 | |
relation.isAuthorOfPublication | 517f6297-b2fc-4922-8fa3-ccc23ee287c7 | |
relation.isAuthorOfPublication.latestForDiscovery | a1cc8278-52e7-484d-8b45-3d62bba6c443 |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- art_OLIVEIRA_Metabolic_Effects_of_Endoscopic_Duodenal_Mucosal_Resurfacing_a_2021.PDF
- Tamanho:
- 998.18 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)